http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H1135486-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dae64c775f32c43199adbb4389c2c9b3 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 |
| filingDate | 1997-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73e27f76f9952e39b660dbb15844c4ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42ba33219eec5c32a1684e43cf5bba64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_705f0cb68263d85bd8ab53a6d5142378 |
| publicationDate | 1999-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H1135486-A |
| titleOfInvention | Medicinal solid preparation |
| abstract | (57) Abstract: A sweetener and / or a flavoring ingredient containing a physiologically active ingredient having an unpleasant taste and an endothermic agent having an endothermic amount of 30 cal / g or more when dissolved in water. A solid pharmaceutical preparation characterized by being formulated as a flavoring agent. Effect The solid pharmaceutical preparation of the present invention can provide a sufficient flavoring effect even when the total amount of the sweet component, the flavoring component, and the endothermic agent is small, so that the effect of the physiologically active component is sufficiently exhibited. Thus, a medicinal solid preparation excellent in taking properties, portability, and the like when taken can be obtained. Therefore, the solid pharmaceutical preparation of the present invention is useful as a solid pharmaceutical preparation containing a physiologically active ingredient exhibiting an unpleasant taste such as bitterness, and is used in various oral medicines and, for example, in the oral cavity to suppress inflammation of the throat. It can be suitably used as an external preparation or the like used for the oral cavity or throat where the physiologically active ingredient is absorbed from the mucous membrane. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004161700-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11349473-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2275141-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0230400-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4694669-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004107258-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011016781-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4501023-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011006481-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7510728-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104177274-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9012499-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0054811-A1 |
| priorityDate | 1997-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 236.